ISIS Pharmaceuticals (ISIS) Hit Following Two-Notch Analyst Downgrade

July 19, 2012 10:35 AM EDT
ISIS Pharmaceuticals (Nasdaq: ISIS) is getting hit Thursday, following a two-notch downgrade at Jefferies, issued earlier.

Shares are over 9 percent lower on the session with volume over 500K shares so far.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Insiders' Blog, Momentum Movers

Related Entities

Jefferies & Co